期刊文献+

3-[(4'-吗啉基)-羰基或乙氧羰基]-4-苯氨基喹啉化合物的合成及抗肿瘤活性 被引量:6

Synthesis and Antitumor Activities of 3-[(4′-Morpholine)-carbonyl or ethoxycarbonyl]-4-anilinoqunolines
下载PDF
导出
摘要 以间氯苯胺与乙氧基亚甲基丙二酸二乙酯(EMME)为原料,经缩合、高温环合、水解、氯代和亲核取代等反应设计并合成了16个3位为(4'-吗啉)-羰基或乙氧羰基的4-苯氨基喹啉化合物(Ⅰ1~Ⅰ10,Ⅱ1~Ⅱ6).目标化合物结构经MS及1H NMR确证.以MTT法,采用表皮生长因子受体(EGFRs)高表达的人癌细胞(HeLa,HepG2,BGC-823)对目标化合物进行活性测试,结果表明,该类化合物对HeLa,HepG2和BGC-823细胞增殖具有一定程度的抑制作用.其中化合物Ⅱ4~Ⅱ6对HepG2细胞抑制作用较强,化合物Ⅱ1和Ⅱ5对BGC-823细胞抑制作用较强.初步探讨了化合物结构与生物活性的关系. Sixteen new 4-anilinoqunolines with 4′-morphohne-carbonyl group or ethoxyearbonyl group at C3 position( Ⅰ1--Ⅰ10, Ⅱ1--1Ⅱ6 ) were designed and synthesized from 3-chlorobenzenamine and ethoxymethylene malonie diethyl ester(EMME) by the condensation, high-temperature eyclization, hydrolysis and nucleophilic substitution reaction. Their structures were confirmed by MS and ^1H NMR analysis. The antitumor activities of these compounds were evaluated by MTF assay in HeLa, HepG2 and BGC-823 cells expressing high levels of epidermal growth factor receptor( EGFR ). These compounds exhibited somewhat inhibitory activities against the three cancer cells. Among them, compounds Ⅱ4- Ⅱ6 had stronger inhibition on HepG2 cell and Ⅱ1, Ⅱ5 had stronger activitv on BGC-823 cell. Preliminary structure-activity relationship was also discussed.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2012年第10期2249-2255,共7页 Chemical Journal of Chinese Universities
关键词 4-苯氨基喹啉 肿瘤 表皮生长因子受体 酪氨酸激酶 抑制剂 4-Anilinoquinoline Tumor Epidermal growth factor receptor (EGFR) Tyrosine kinase Inhibitor
  • 相关文献

参考文献23

  • 1任晓岚,汪鑫,李志裕,尤启冬.表皮生长因子受体(EGFR)酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2005,14(7):821-826. 被引量:31
  • 2赵欣,郭长彬,周化.蛋白酪氨酸激酶抑制剂的研究进展[J].中国药物化学杂志,2010,20(5):442-449. 被引量:5
  • 3Rewcastle G. W. , Denny W. A. , Bridges A. J. , Zhou H. R. , Cody D. R. , McMichael A. , Fry D. W.. J. Med. Chem. [J], 1995, 38 : 3482-3487. 被引量:1
  • 4Dancey J. , Sausville E. A.. Nat. Rev. Drug Discovery[J], 2003, 2(4): 296-313. 被引量:1
  • 5彭涛,裴剑锋,周家驹.酪氨酸激酶抑制剂的比较分子场分析[J].高等学校化学学报,2003,24(6):1076-1079. 被引量:3
  • 6CaoX, YouQ. D., LiZ. Y.,WangX. J., LuX. Y., LiuX. R., XuD.,LiuB.. Mini. Rev. Med. Chem.[J],2008,8: 1053- 1063. 被引量:1
  • 7Michalczyk A. , Klttter S. , Rode H. B. , Simard J. R. , Grutter C. , Rabil[er M. , Rauh D.. Bioorg. Med. Chem. [ J ] , 2008, 16 : 3482-3488. 被引量:1
  • 8Rheault T. R. , Caferro T. R. , Dickerson S. H. , Donaldson K. H. , Gaul M. D. , Goetz A. S. , Mullin R. J. , McDonald O. B. , Petrov K. G. , Rusnak D. W. , Shewchuk L. M. , Spehar G. M. , Truesdale A. T. , Vanderwall D. E. , Wood E. R. , Uehling D. E.. Bioorg. Med. Chem. Lett. [J], 2009, 19:817-820. 被引量:1
  • 9Lin R. , Johnson S. G. , Connolly P. J. , Wetter S. K. , Binnun E. , Hughes T. V. , Murray W. V. , Pandey N. B. , Moreno-Mazza S. J. , Adams M. , Fuentes-Pesquera A. R. , Middleton S. A.. Bioorg. Med. Chem. Lett. [J], 2009, 19:2333-2337. 被引量:1
  • 10Liao Q. H., Gao Q. Z., Wei J., Chou K. C.. J. Med. Chem. [J], 2011,7: 24-31. 被引量:1

二级参考文献198

  • 1吴一龙.肺癌分子靶向治疗的个体化[J].循证医学,2004,4(2):67-68. 被引量:9
  • 2戚建军,郭惠元.司氟沙星合成路线图解[J].中国医药工业杂志,1995,26(12):563-565. 被引量:8
  • 3郭惠元,顾慧儿.吡酮酸化学(上)[J].中国抗生素杂志,1995,20(2):85-90. 被引量:15
  • 4郭惠元,顾慧儿.吡酮酸化学(中)[J].中国抗生素杂志,1995,20(3):231-239. 被引量:10
  • 5郭惠元,顾慧儿.吡酮酸化学(下)[J].中国抗生素杂志,1995,20(4):311-320. 被引量:9
  • 6Baselga J. Targeting tyrosine kinases in cancer: the second wave [J]. Science, 2006, 312: 1175-1178. 被引量:1
  • 7Kamath S, Buolamwini JK. Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development [J]. Med Res Rev, 2006, 26: 569-594. 被引量:1
  • 8Wissner A, Overbeek E, Reich MF, et al. Synthesis and structure-activity relationships of 6, 7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2) [J]. J Med Chem, 2003, 46: 49-63. 被引量:1
  • 9Tsou HR, Overbeek-Klumpers EG, Hallett WA, et al. Optimization of 6, 7-disubstituted-4-(arylamino) quinoline-3- carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity [J]. J Med Chem, 2005, 48: 1107-1131. 被引量:1
  • 10Srivastava SK, /ha A, Agarwal SK, et al. Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives [J]. Anticancer Agents Med Chem, 2007, 7: 685-709. 被引量:1

共引文献68

同被引文献63

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部